Cardiac imaging for risk stratification in asymptomatic diabetes Scholte, A.J.H.A.

Hele tekst

(1)Cardiac imaging for risk stratification in asymptomatic diabetes Scholte, A.J.H.A.. Citation Scholte, A. J. H. A. (2009, November 19). Cardiac imaging for risk stratification in asymptomatic diabetes. Retrieved from https://hdl.handle.net/1887/14368 Version:. Corrected Publisher’s Version. License:. Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded from:. https://hdl.handle.net/1887/14368. Note: To cite this publication please use the final published version (if applicable)..

(2) Chapter. 5. Prevalence and predictors of an abnormal stress myocardial perfusion study in

(3)

(4) diabetes mellitus.

(5)

(6)

(7)

(8)

(9) !

(10) ". #$. Eur J Nucl Med Mol Imaging 2009;36:567-575.

(11) Chapter 5. Abstract Purpose The purpose of this study was to evaluate the prevalence of an abnormal stress myocar &

(12) ' ''(& ()&)

(13) * '&

(14) +

(15)

(16) (

(17) litus using myocardial perfusion imaging by means of single photon emission computed ( &', ./12

(18) ' *

(19)

(20)

(21) (

(22) *

(23) )('&

(24) (

(25) (' &

(26) ' & & ) 2 Methods 3+4 '(& () &)

(27) ,(

(28)

(29) 57 8 34 '

(30) 1 * '&

(31) +

(32)

(33) (

(34).

(35) (

(36) '

(37) '

(38)

(39) *

(40)

(41) & &

(42) )!

(43) '

(44)

(45) ( &)

(46)

(47)

(48) 2. &)

(49)

(50) *

(51) (' &

(52) imaging by means of adenosine 99m/

(53) ( ./2:(

(54) *

(55)

(56)

(57) !

(58)

(59) &

(60)

(61)

(62) &

(63) ( )

(64) *

(65).

(66) &

(67) ( )

(68) ('

(69)

(70) $

(71) !

(72)

(73) (

(74) ;!

(75) ') ,

(76) <

(77)

(78) ; !

(79)

(80)

(81) ) ) =>5?1

(82)

(83) ( )

(84)

(85)

(86) /

(87) (

(88)

(89) &

(90) 2 )!

(91) '*&

(92) (

(93) *

(94)

(95) )

(96) '

(97) )'&

(98) ) &

(99) (

(100) (' &

(101) '2@. ' . &)

(102) *

(103)

(104) . *

(105) & 3+(

(106)

(107) (

(108)

(109)

(110)

(111) !

(112) !

(113) A ,31

(114) ,+1 (' ) ,71

(115)

(116) B & C) ,>1

(117) ! C) ,51

(118) 2 Results D

(119) 3+4&)

(120) >4,77?1 (

(121) ' (' &

(122) ( )

(123) 74&)

(124) ,+5?12:34,E?1&)

(125)

(126) $

(127) !

(128) ,& '

(129)

(130) (1*

(131)

(132)

(133) !

(134)

(135)

(136)

(137) ( &

(138) 2/

(139) ( )!

(140) '

(141) )<

(142)

(143) ( )

(144)

(145)

(146)

(147) F

(148) ' & &

(149) ,G1 )

(150) &

(151)

(152) &

(153) (

(154) '2 . *& &

(155) 3+ ( $ ,5?1 &)

(156) ! event. Conclusion The current study revealed a high prevalence of abnormal stress myocardial perfusion

(157) &)

(158) * '&

(159) +

(160)

(161) (

(162).

(163) &

(164)

(165)

(166)

(167) '(& (2:

(168)

(169)

(170)

(171) ( )

(172)

(173)

(174)

(175) FG ) *

(176)

(177)

(178) )<

(179)

(180) &

(181)

(182) &

(183) ( '2. 60.

(184)

(185) .

(186)

(187) (

(188).

(189) ! )

(190)

(191) J

(192) )(. ! 2

(193) !

(194)

(195)

(196)

(197)

(198)

(199) $&

(200)

(201) *

(202) $&

(203) ). '

(204)

(205) & & )

(206)

(207) &

(208) !

(209)

(210)

(211) '

(212) '

(213) '

(214) 2:&)

(215) * '&

(216) +

(217)

(218) (

(219). tus, cardiovascular diseases are a major cause of mortality and morbidity, with coronary

(220) '

(221)

(222) ,.1

(223)

(224)

(225)

(226)

(227) 26 Moreover, atherosclerosis and .&&

(228)

(229) !

(230) &J

(231)

(232) '&)

(233) *

(234)

(235) (&

(236)

(237) ) ! 2 @

(238) B

(239) ' .

(240) !

(241) & '

(242)

(243) *

(244) &

(245) without the development of symptoms.8, 9.

(246) B

(247) '

(248) ('

(249) (

(250) B

(251) '&

(252)

(253) &)

(254) *

(255)

(256) '

(257) N

(258)

(259)

(260) sults of the absence of symptoms. / (& !

(261)

(262) )<)

(263) )&)

(264) !

(265) !

(266) sessment of myocardial perfusion by means of single photon emission computed tomog&', ./1(

(267)

(268) & &

(269) 220, 22 Although several studies have described

(270) &

(271) !

(272)

(273) ('

(274) ( '&

(275) +

(276)

(277) (

(278). &)

(279) ' (

(280) (

(281)

(282) !

(283) & &

(284) )!

(285) '

(286) ''(& ()&)

(287) *

(288)

(289) 2/

(290)

(291) & &

(292) )!

(293)

(294) !

(295) *&

(296) !

(297)

(298)

(299) ('

(300) ( ranging from 15% to 22%.36, 43:

(301)

(302)

(303)

(304)

(305) J

(306) )!

(307)

(308) <

(309)

(310) V

(311) W

(312)

(313) & & ) '(& ()&)

(314) *

(315)

(316) 2 '

(317)

(318) & &

(319) !!

(320)

(321) ! )

(322) &

(323) (

(324) '

(325)

(326) )&)

(327) *

(328)

(329) )

(330) )

(331) . !

(332) !

(333)

(334)

(335) '

(336)

(337) '

(338) (

(339) 2 ' &

(340)

(341)

(342)

(343)

(344)

(345) )'

(346) &)

(347) *

(348)

(349) hood of silent myocardial ischemia. The purpose of this study was to evaluate the prevalence of an abnormal stress myocar &

(350) ' ''(& ()&)

(351) * '&

(352) +

(353)

(354) (

(355). (' &

(356) ('(

(357) ./2

(358) ' *

(359)

(360)

(361) (

(362) *

(363) )('&

(364) (

(365) (' &

(366) ' & & ) )!

(367) !

(368)

(369) 2. 61.

(370) Chapter 5. Materials and methods

(371) 3+4'(& ()&)

(372) * '&

(373) +

(374)

(375) (

(376). *

(377)

(378)

(379) ' * (344,E7?1 &)&

(380) &

(381) ! '284. &)

(382) *

(383)

(384)

(385)

(386)

(387) (

(388) ) &)

(389) & ! )<) 2/

(390)

(391)

(392) *

(393)

(394) '

(395)

(396)

(397) &' <(

(398) '&)

(399) 'F

(400)

(401) '& '

(402) (

(403) 21 :

(404)

(405) <(

(406) '&

(407) +

(408)

(409) (

(410). () * (&

(411)

(412)

(413)

(414)

(415) B!

(416) '(& (2 $

(417) *

(418)

(419) A * &

(420)

(421) .

(422)

(423) ' &'

(424)

(425)

(426)

(427) ' '

(428) ! C)

(429) (

(430) * ) (

(431) )

(432)

(433) &

(434) !

(435)

(436) X*!

(437) (' )

(438) ( /

(439) (

(440) /*!

(441)

(442) (&

(443)

(444)

(445) ;

(446) )!

(447) &(

(448) $

(449)

(450)

(451)

(452) 2'(& () * <(

(453)

(454) Y

(455) B

(456) )

(457) for angina.15.

(458) .Z

(459) ./(*&

(460) (

(461) +'& ,

(462)

(463) 1* 99m/

(464) (,99m/:#:12. &)

(465) *

(466)

(467)

(468) (

(469) J

(470)

(471) -. & +>

(472)

(473)

(474) )2

(475)

(476) *

(477)

(478) 3>4[F ' weight per minute for 6 minutes with a simultaneous handgrip exercise. Blood pressure was measured and recorded at rest and every minute during adenosine infusion and the

(479) !

(480) '&

(481) 2/*

(482) !

(483)

(484)

(485)

(486) &', .Z1*

(487)

(488)

(489) (

(490) ) '(

(491) ,

(492) @ 351

(493)

(494) !

(495) &(

(496) ' ( /

(497) (

(498)

(499) !) 2

(500)

(501)

(502) (

(503) 99m/:#:,544#B1*

(504)

(505) !

(506) '2:(*&

(507) (

(508) 3+4(

(509) ;

(510) &(

(511) )

(512) ) &

(513)

(514) ./(((

(515) ,Z.]744FZ^/ . & ) / ' &1 *

(516)

(517) '

(518) ) . ( 2:(

(519) *

(520)

(521) B

(522) 7_4` _4&

(523) ) >4

(524) &

(525) &

(526) ) 261, 62k q

(527) )

(528) ) * &&

(529) 2 /

(530) (

(531) *

(532)

(533) &

(534)

(535)

(536) (

(537) $ C $!

(538) ) $!

(539) **

(540)

(541)

(542)

(543) 2)

(544) ( ) *

(545) !

(546) '

(547) $(

(548) *

(549) (

(550) 2 62.

(551)

(552) . Data analysis Y

(553)

(554) $!

(555) **

(556). & (& ( , ( C

(557) the maximum

(558) )! '1*

(559)

(560)

(561)

(562) (B) )!

(563) !

(564) &

(565) ) 2/

(566) myocardium was divided into 17 segments and each segment was evaluated in consen' *

(567) $&

(568)

(569) !

(570) & '

(571) (,4{|5?

(572) &

(573) 3 54|5?

(574) &

(575) ++554?

(576) &

(577) 7=+5?

(578) &

(579) 1266, 85 /

(580) ((

(581)

(582)

(583) ,1((

(584)

(585)

(586) ,Y1*

(587)

(588)

(589) '(()

(590) !

(591) (

(592)

(593)

(594)

(595)

(596) &

(597) )!

(598) '2/

(599) ((

(600)

(601)

(602)

(603)

(604) ,1*

(605) ' )

(606) Y (

(607) *

(608) &

(609)

(610)

(611)

(612) $

(613)

(614) !

(615) ' &

(616) ( )

(617) 286

(618)

(619)

(620) *

(621)

(622)

(623) )<

(624)

(625)

(626) (

(627) ,

(628) )! '

(629) |5? ($((1!

(630)

(631) (,

(632) !

(633)

(634)

(635)

(636) 1 )

(637) ,<$

(638)

(639)

(640) 1 ($

(641) ,

(642) (12Y

(643) !

(644)

(645) &

(646)

(647)

(648)

(649) <

(650) '}+ *

(651)

(652)

(653) ( ,+>1 (

(654)

(655)

(656) !

(657)

(658) ,}>12@$

(659)

(660)

(661) *

(662)

(663)

(664)

(665) &

(666)

(667) Y }+ =+2

(668)

(669)

(670) *

(671)

(672) .

(673)

(674) '

(675) '

(676)

(677) ,

(678) ;

(679)

(680)

(681) ;(~

(682) $ '

(683)

(684) 1287 Using

(685)

(686) (

(687)

(688) *. ( ) * 'C

(689) (& !

(690) J

(691)

(692) ))

(693) *

(694)

(695)

(696) &

(697) ( )

(698) q

(699) )

(700) 2 : ) ./ *

(701)

(702)

(703) !

(704)

(705) ( )

(706) )!

(707) ,& '

(708) $

(709) !

(710) 1.

(711)

(712) (2G

(713) ;!

(714)

(715)

(716) ) ) ,G @1

(717)

(718) *

(719) !

(720) (

(721)

(722) ! (

(723) , 1

(724) ' ! (

(725) , 12)

(726) *

(727) ) G') ,G @=>5?1*

(728)

(729) <

(730) ! ( '236, 88 ./ (

(731)

(732) !

(733)

(734)

(735)

(736) &

(737)

(738)

(739) ( ) ,/:1 ,

(740) ~

(741)

(742) ')

(743)

(744) $! (

(745)

(746) G

(747) 32+31

(748) G *

(749)

(750)

(751) C

(752) ( 236, 89, 90 @. ' ~ * & /

(753) (

(754)

(755) &

(756) }3(( E4(;

(757)

(758) & * (

(759)

(760)

(761) .Z adenosine infusion was also interpreted as an abnormal test result.63 Thus, an abnormal !

(762) ./(' &

(763) ( '*

(764) <

(765) ^3 ( (' &

(766) +G @=>5? 7/: >

(767)

(768) &

(769) 5

(770) (/ depression during adenosine infusion.. Follow-up : () 3+ ( . *& *

(771) ' !

(772)

(773) &

(774)

(775) !

(776) *2 !

(777) !

(778) *

(779) <

(780)

(781)

(782)

(783) A,3163.

(784) Chapter 5.

(785) ,+1 (' ) ,71

(786)

(787) B & C) ,>1

(788) ! C) ,51

(789) 2 .

(790) *

(791) <

(792)

(793)

(794) '

(795) (' ) !

(796) ' (

(797) '

(798)

(799) 2k (' ) *

(800) <

(801)

(802)

(803) '&

(804) &

(805)

(806) !

(807)

(808) C'(

(809)

(810) !

(811) '&

(812)

(813)

(814)

(815) gram.91@. '

(816) (

(817) ) !

(818) ) ' (* recorded.. .

(819)

(820)

(821)

(822) )

(823)

(824) $&

(825)

(826) (

(827) &

(828)

(829)

(830) (&

(831)

(832) *

(833)

(834) * &*

(835) B

(836)

(837) 2. ) !

(838)

(839)

(840) $&

(841)

(842) (

(843) ,

(844) !) 1 (&

(845) *

(846) *

(847) t test for independent samples. ( )!

(848) '

(849)

(850)

(851) )*&

(852) (

(853)

(854) )'&

(855) ) &

(856) (

(857) (' &

(858) '2D) *

(859)

(860)

(861) * ]5? <

(862)

(863)

(864) !

(865) )(

(866)

(867)

(868) * &) !

(869) 2*

(870)

(871) )

(872) '*

(873)

(874) . !

(875)

(876) )<

(877)

(878) !

(879) '* p42+2 )) '

(880) *

(881)

(882) &

(883) (

(884) ;*

(885) !

(886) 3+24, . :. 1p!

(887) =4245*

(888)

(889)

(890)

(891) )). '< 2. Results

(892)

(893) : 3++&)

(894) *

(895)

(896)

(897)

(898)

(899) & &

(900) )!

(901) ' (

(902) &)

(903)

(904) )

(905) .

(906)

(907) &

(908)

(909) '2/* &)

(910) *

(911)

(912)

(913) $

(914) (

(915) '

(916) & (

(917) B '2/

(918) < '& & )

(919) 3+4

(920) )!

(921) '(& () &)

(922) * '&

(923) +

(924)

(925) 2 #

(926)

(927)

(928) )

(929) 3+4&)

(930) 'C

(931)

(932) &

(933)

(934)

(935) /

(936) 32#

(937) ~'

(938) (

(939)

(940) *57834'

(941) |5&)

(942) ,_+?1*

(943)

(944) (

(945) 2/

(946) (

(947) )

(948)

(949) *]258|27'

(950) 2D )

(951) )(

(952) ) *

(953) '5]? &)

(954) *

(955)

(956) +>?

(957) 2D!

(958) . '+7?

(959) &)

(960)

(961)

(962) !

(963) &5|? )

(964) &'2 64.

(965)

(966) . Table 1. )

(967)

(968) )^ (&

(969) *

(970)

(971) &)

(972) * ( mal stress myocardial perfusion studies. Variables Male @

(973) (

(974)

(975) ,'

(976) 1

(977)

(978)

(979)

(980) ) ,'

(981) 1

(982) )(

(983)

(984)

(985) ,'

(986) 1 HbA1C Treatment Oral Insulin and oral Insulin

(987) &

(988) !

(989)

(990) ,1

(991) &

(992)

(993) & ',k1 Peripheral vascular and neuropathy # '(

(994) $,F(21 " (

(995)

(996)

(997) ,(1 Hypertension Hypercholesterolemia @( ' ' . Smoking Past Current

(998) ) Aspirin . Y# ) Serum markers /

(999)

(1000) ,(( F 1 GG,(( F 1 G,(( F 1 / '

(1001)

(1002) ,(( F 1 .

(1003)

(1004) FG) .

(1005) )

(1006) ,(( F 1

(1007) (

(1008) )

(1009) ) .Y ApoA1 ApoB @

(1010) .

(1011) n=120. Abnormal study n=40. Normal study n=80. P value. |5,_+1 >5,7E1 53±10. +7,5E1 3|,>+1 53±10. 5+,_51 +E,751 53±10. 0.42 0.42 1.00. 9.5±7.3 43±12 7.3±1.6. 11.8±8.4 41±13 7.5±1.6. 8.3±6.4 45±10 7.3±1.6. 0.03 0.05 0.39. |4,5]1 3E,351 +],+>1 3+,341 +5,+31 3|,3>1 29.1±5.4 103±14 _5,5>1 _E,5|1 _5,5>1. +4,541 __,351 37,771 5,371 |,3E1 ],+71 29.0±4.5 104±14 +7,5E1 +|,_E1 3E,>51. 54,_71 3+,351 3_,+41 |,]1 3E,+71 E,341 29.1±5.7 102±14 >+,571 >3,531 >|,5]1. 0.19 0.98 0.14 0.52 0.53 0.06 0.92 0.66 0.60 0.90 0.15. +5,+31 +|,+71. 5,371 3_,>41. +4,+51 33,3>1. 0.11 0.001. +|,+71 >+,751 +|,+71 _E,5|1. ],741 3>,751 3>,+51 +|,_E1. 3_,+41 +E,751 3|,+31 >3,531. 0.35 1.0 0.64 0.09. 4.8±1.2 3.1±1.1 1.4±0.6 2.0±1.2 3.7±1.3 77.6±20.1 11.6±30.2 9.3±9.1 1.4±0.2 0.9±0.3 3.9±0.9. 4.5±1.3 3.0±1.3 1.5±0.5 1.8±0.9 3.4±1.0 75.2±20.0 10.3±26.0 11.1±12.7 1.5±0.2 0.8±0.3 4.1±1.2. 4.9±1.1 3.1±1.0 1.4±0.6 2.1±1.4 3.9±1.4 78.8±20.2 12.4±32.5 8.2±6.1 1.1±0.3 0.9±0.3 3.8±0.8. 0.09 0.45 0.48 0.24 0.03 0.36 0.75 0.26 0.51 0.16 0.26. .

(1012) !

(1013) )

(1014) C'(

(1015) ^& & & &

(1016) ^Y#

(1017)

(1018)

(1019) &

(1020) ^. '

(1021) '

(1022)

(1023) ^ .Y

(1024) )!

(1025) &

(1026) ^G

(1027) ' & &

(1028) ^GG *

(1029) ' & &

(1030) 2. 65.

(1031) Chapter 5. Prevalence of an abnormal stress myocardial perfusion study Y

(1032) &

(1033) ( )

(1034) *

(1035)

(1036) &

(1037)

(1038) 74&)

(1039) ,+5?12D

(1040)

(1041) &)

(1042) ++ ,|7?1 &)

(1043) *

(1044)

(1045) !

(1046)

(1047)

(1048)

(1049) > ,37?1 &)

(1050) <$

(1051)

(1052)

(1053) 4 ,37?1&)

(1054) &). '

(1055) !

(1056)

(1057)

(1058)

(1059) 2/

(1060) &)

(1061) ,77?1 *

(1062) (

(1063) (,=>1 3|,5|?1 *

(1064) (

(1065)

(1066)

(1067) (,>E17,34?1 *

(1068)

(1069) !

(1070)

(1071)

(1072) (,{E12 /

(1073) ( )

(1074) &

(1075)

(1076)

(1077) *. *A

(1078)

(1079) ;

(1080)

(1081)

(1082)

(1083) '3]&)

(1084) ,_7?1

(1085) ;(~

(1086) $

(1087) '7,34?1 '

(1088) '

(1089) '|,+7?12:+,|?1&)

(1090) (

(1091) * !

(1092)

(1093) *

(1094)

(1095) ! !

(1096) 2

(1097) G @

(1098) ! (

(1099) , 1

(1100) ' ! (

(1101) , 1*

(1102)

(1103) !

(1104) 33|,]E?1&)

(1105) 2/

(1106) (

(1107) G @*_32>8332>?* (

(1108) E+2+8+|2|( (

(1109) 772383]2>( 2

(1110)

(1111) G @ *

(1112)

(1113) !

(1114) ]+&)

(1115) ,||?1* (

(1116) G @ 5]258332>?(

(1117) E72_8742+( 752_8+32|(

(1118) &

(1119) )!

(1120) '

(1121) 2 : &)

(1122) * &

(1123) ( )

(1124) (

(1125) G @ *

(1126)

(1127)

(1128) &

(1129) )!

(1130) ' 58.0 ± 12.6%, 85.0 ± 29.0 ml and 37.9 ± 22.6 ml at rest and 57.5% ± 12.8%, 90.0 ± 37.0 ml >32E8+E2+(

(1131) 2 &)

(1132) G')

(1133) ,G @=>5?1 *>&)

(1134) *

(1135) ( &

(1136) 2 ! "

(1137) # " $% " /

(1138)

(1139) ( ) ,/:1*

(1140) * &)

(1141)

(1142) * *

(1143) ( &

(1144) 2:

(1145)

(1146) &)

(1147) *

(1148)

(1149)

(1150) &

No results found